arrow_backBack to Catalogue
GH Secretagogue
Ipamorelin
Selective ghrelin receptor agonist for GH release without spikes in cortisol or prolactin.
Clinical Profile
- check_circlePhysiologic growth hormone stimulation
- check_circleNo impact on appetite or blood sugar
- check_circleImproved body composition and skin quality
- check_circleEnhanced recovery from physical exertion
biotech
Mechanism of Action
A selective growth hormone-releasing peptide (GHRP) that triggers the pituitary gland to release growth hormone. It is specifically valued for its 'clean' profile, meaning it does not stimulate the release of stress hormones like cortisol or increase prolactin levels.
medication_liquid
Therapeutic Application
Subcutaneous injection, often 1-2 times daily or before bedtime, frequently combined with CJC1295.
Ready to include Ipamorelin in your protocols?
Log in to the prescriber portal to access research monographs, inventory availability, and peer-reviewed clinical studies.